Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Inventory (2020 - 2025)

Biofrontera (BFRI) has 6 years of Inventory data on record, last reported at $4.3 million in Q3 2025.

  • For Q3 2025, Inventory fell 33.67% year-over-year to $4.3 million; the TTM value through Sep 2025 reached $4.3 million, down 33.67%, while the annual FY2024 figure was $6.6 million, 39.07% down from the prior year.
  • Inventory reached $4.3 million in Q3 2025 per BFRI's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Inventory topped out at $16.1 million in Q3 2023 and bottomed at $3.9 million in Q2 2024.
  • Average Inventory over 5 years is $7.2 million, with a median of $6.6 million recorded in 2024.
  • Peak YoY movement for Inventory: soared 122.23% in 2022, then crashed 59.39% in 2024.
  • A 5-year view of Inventory shows it stood at $4.5 million in 2021, then skyrocketed by 60.79% to $7.2 million in 2022, then soared by 52.18% to $10.9 million in 2023, then plummeted by 39.07% to $6.6 million in 2024, then tumbled by 34.86% to $4.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $4.3 million in Q3 2025, $4.0 million in Q2 2025, and $6.5 million in Q1 2025.